Prevention of thrombosis and rethrombosis and enhancement of the thrombolytic actions of recombinant tissue-type plasminogen activator in the canine heart by DMP728, a glycoprotein IIb/IIIa antagonist

This publication has 46 references indexed in Scilit:

• Antithrombotic Effects of DMP 728, a Platelet GPIIb/IIIa Receptor Antagonist, in a Canine Model of Arterial Thrombosis
  Journal of Cardiovascular Pharmacology, 1994
• A chimeric murine/human antibody Fab fragment directed against the platelet GPIIb/IIIa receptor enhances and sustains arterial thrombolysis with recombinant tissue-type plasminogen activator in baboons.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
• Importance of platelets in myocardial injury after reperfusion in the presence of residual coronary stenosis in dogs
  American Heart Journal, 1993
• Antiplatelet Agents in the Prevention and Therapy of Thrombosis
  Annual Review of Medicine, 1992
• The Physiologic Replacement of Insulin
  New England Journal of Medicine, 1990
• RGDV peptide selectively inhibits platelet-dependent thrombus formation in vivo. Studies using a baboon model.
  Journal of Clinical Investigation, 1989
• Aspirin and Dipyridamole in the Prevention of Re-Stenosis after Percutaneous Transluminal Coronary Angioplasty
  New England Journal of Medicine, 1988
• The Platelet Membrane Glycoprotein IIb/IIIa Complex
  Annals of the New York Academy of Sciences, 1987
• Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty
  The American Journal of Cardiology, 1987
• Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion.
  Circulation, 1985